Clinical Trial Update: A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) [Phase 1]

View source ↗

Summary

A Phase 1 drug-drug interaction study assessed how HS-10374 interacts with Yasmin (drospirenone/ethinyl estradiol) in participants with psoriasis; the trial has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HS-10374
• Yasmin (drospirenone/ethinyl estradiol)

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Psoriasis (PsO) | Phase 1 | Status: COMPLETED